￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Entrectinib/Luoshengquan belongs to the first generation of targeted drugs

2026-02-01 22:25:32

Check Details
Has Sorafenib been officially included in medical insurance coverage?

2026-02-01 22:25:32

Check Details
What is the latest price of pemetinib/pemetinib targeted drug?

2026-02-01 22:25:32

Check Details
Introduction to the indications and treatment scope of Erdafitinib/Bocco

2026-02-01 22:25:32

Check Details
Correct usage, dosage and medication recommendations of Dacomitinib/Dozerun

2026-02-01 22:25:32

Check Details
Has brigatinib/brigatinib been reimbursed by medical insurance?

2026-02-01 22:25:32

Check Details
Correct usage and dosage of entrectinib/Luo Shengquan

2026-02-01 22:25:32

Check Details
How to prevent the side effects and harms of Sorafenib/Nexavar

2026-02-01 22:25:32

Check Details
Will the side effects of Pemetinib/Dabotan persist?

2026-02-01 22:25:32

Check Details
Where to buy Erdafitinib more formally

2026-02-01 22:25:32

Check Details
Are Dacomitinib/Dacomitinib and Dozerun the same drug?

2026-02-01 22:25:32

Check Details
Brigatinib/Brigatinib (Embry) treatment effects and patient feedback

2026-02-01 22:25:32

Check Details
Category
相关知识